Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to demonstrate the efficacy of T1225 eye drops versus placebo eye drops on the global ocular discomfort (VAS).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Laboratoires Thea
Collaborators
NCT04603222 · Blepharitis
NCT07451678 · Blepharitis
NCT06235450 · MicroBlepharoexfoliation, NuLids, iTEAR100, iLIDS100, Blepharitis, Dry Eye Syndrome
NCT04784091 · Blepharitis
NCT04469998 · Posterior Blepharitis, Meibomian Gland Dysfunction
C.H.N.O des XV-XX
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions